Moderna, Pfizer blueprints revealed: Vaccine frontrunners bow to public pressure, abandon secrecy

Companies typically share these documents after their studies are complete. The disclosures while the trials are still underway, a rare move, are aimed at addressing growing suspicion among Americans that President Donald Trump ’s drive to produce a vaccine before the election on Nov. 3 could result in a product that was unsafe.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news